Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MVK |
| Upstream (Parents) |
|---|
| (<<) AIFM1 → MVK |
| (<<) ARHGEF2 → MVK |
| (<<) BCL2A1 → MVK |
| (<<) CD83 → MVK |
| (<<) DUSP10 → MVK |
| (<<) GNB5 → MVK |
| (<<) GRN → MVK |
| (<<) HGS → MVK |
| (<<) ITPR2 → MVK |
| (<<) LPIN1 → MVK |
| (<<) MAP2K1 → MVK |
| (<<) PRKCD → MVK |
| (<<) PSAT1 → MVK |
| (<<) RDX → MVK |
| (<<) UGDH → MVK |
| Downstream (Children) |
|---|
| MVK → ATP2A2 (>>) |
| MVK → CACNA1E (>>) |
| MVK → CRK (>>) |
| MVK → ENTPD7 (>>) |
| MVK → EPHA1 (>>) |
| MVK → ETS1 (>>) |
| MVK → FGF5 (>>) |
| MVK → GRPEL1 (>>) |
| MVK → GSK3A (>>) |
| MVK → HDAC6 (>>) |
| MVK → HS3ST2 (>>) |
| MVK → HSPA9 (>>) |
| MVK → ITCH (>>) |
| MVK → MAP3K2 (>>) |
| MVK → MTSS1 (>>) |
| MVK → PHLDA1 (>>) |
| MVK → PRKCZ (>>) |
| MVK → PRKX (>>) |
| MVK → PRR5 (>>) |
| MVK → PTGER1 (>>) |
| MVK → PTGS1 (>>) |
| MVK → RARA (>>) |
| MVK → RRAS2 (>>) |
| MVK → STAT2 (>>) |
| MVK → TGFB2 (>>) |
